Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda Halts Development Of Diabetes Agent TAK-379

Apr 23 2009

• By PharmAsia News

Related Content

More data needed for Takeda’s alogliptin

Mar 09 2009

Takeda Starts Japanese Fiscal Year With Global Reorganization

Apr 02 2009

Takeda Takes Back Actos Rights from Eli Lilly, Sets Course For Own Geographic Expansion

Apr 12 2009

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window